<DOC>
	<DOCNO>NCT01017614</DOCNO>
	<brief_summary>The purpose trial demonstrate intravenous iron oligosaccharide non-inferior oral iron sulphate reduce iron deficiency anaemia secondary inflammatory bowel disease ( IBD ) , evaluate ability increase haemoglobin ( Hb ) .</brief_summary>
	<brief_title>Iron Oligosaccharide Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia</brief_title>
	<detailed_description>The study design determine effect investigational drug Monofer subject Inflammatory Bowel Disease ( IBD ) ( intestinal disease characterize swelling , redness sometimes ulcers intestine ) Iron Deficiency Anaemia ( IDA ) ( Anaemia condition characterize deficiency blood body ) .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Subjects diagnosis IBD iron deficiency anaemia include meet follow criterion : 1 . Men woman , age 18 year . 2 . Subjects diagnose inflammatory bowel disease mild moderate disease activity ( define score less equal 5 HarveyBradshaw index Crohn 's disease Mayo score ( subscore without endoscopy ) less equal 6 ulcerative colitis ) . 3 . Hb &lt; 12.0 g/dL ( 7.45 mmol/L ) . 4 . Transferrin saturation ( TfS ) &lt; 20 % . 1 . Anaemia predominantly cause factor iron deficiency anaemia . 2 . Iron overload disturbance utilisation iron ( e.g . haemochromatosis haemosiderosis ) . 3 . Drug hypersensitivity ( i.e . previous hypersensitivity Iron Dextran iron mono disaccharide complex iron sulphate ) . 4 . Known hypersensitivity excipients investigational drug product . 5 . Subjects history multiple allergy . 6 . Active Intestinal Tuberculosis . 7 . Active Intestinal amoebic infection . 8 . Decompensated liver cirrhosis hepatitis ( alanine aminotransferase ( ALT ) &gt; 3 time upper limit normal ) . 9 . Acute infection ( assessed clinical judgement ) , supply white blood cell ( WBC ) Creactive protein ( CRP ) ) . 10 . Rheumatoid arthritis symptom sign active joint inflammation . 11 . Pregnancy nurse 12 . Extensive active bleeding necessitate blood transfusion . 13 . Planned elective surgery study . 14 . Participation clinical study within 3 month prior screen . 15 . Intolerance oral iron treatment . 16 . Untreated B12 folate deficiency . 17 . Other I.V . oral iron treatment blood transfusion within 4 week prior screen visit . 18 . Erythropoetin treatment within 8 week prior screen visit . 19 . Diagnosis Hepatitis B and/or C , confirm appropriate lab test . 20 . Any medical condition , opinion Investigator , may cause patient unsuitable completion study place patient potential risk study . Example , Uncontrolled Hypertension , Unstable Ischemic Heart Disease Uncontrolled Diabetes Mellitus . 21 . History immunocompromise , include positive HIV test result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Iron deficiency</keyword>
	<keyword>Iron deficiency anaemia</keyword>
	<keyword>Anaemia</keyword>
</DOC>